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DrEvanC. Lipsitz (Bronx, NY).We agree that efforts at limb
salvage are justified in patients over 80, as documented by several
studies including one done 20 years ago at our own institution. It
is also noteworthy that the authors have moved past the endpoints
of patency and limb salvage and attempted to gauge outcome with
quality of life and patient wholeness as described.
As we are all aware, older, sicker patients are going to have
worse outcomes. One way of looking at the data you presented, is
that there is a significant increase in perioperative mortality in both
groups, eightfold in the open group, but even sixfold in the
endovascular group. So several questions:
(1) How are patients selected for endovascular vs open
procedures? Are there strict criteria? Were there trends that
emerged?
(2) The mortality certainly would seem to be somewhat high,
not just in this study. Were there any subgroups that were at
especially high risk for morbidity/mortality in the over-80 group?
(3) Why was the limb salvage so much significantly better in
the over-80 groups when there seemed to be no difference for the(4)Were there any criteria, perhaps even including ambulatory
status that would suggest absolute contraindication to attempts at
limb salvage?
Dr Hasan H. Dosluoglu. Thank you, Dr Lipsitz, for your
insightful comments. About the selection criteria; as I mentioned,
these are almost exclusively my patients and I tried to select the
treatment that I thought was best for the patient at the time. In
addition, I think it is also a moving target over time, because it
probably changed as my experience increased. So there is certainly
a huge selection bias in this study.
In terms of mortality, before I actually looked at my data, if
somebody asked me what my mortality over 80 was, I would have
probably guessed 6%. I just never really realized that most of the
patients who actually do not make it to 30 days are octogenarians,
and I was surprised with my own 16% mortality in the open group.
Almost all of themwere due tomyocardial infarctions (MI)s within
a week to 2 weeks after the procedures; some of them were already
in nursing homes or rehab centers.
So I guess at this point I do not have great selection criteria for
selecting patients for revascularization vs primary amputation. But
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loss. And if somebody is bedridden, it seems obvious. Even then,
we all know that sometimes there are situations that it is not a
straightforward decision that a bedridden patient should have a
primary amputation. So I guess I would say that primary amputa-
tion could be considered in the bedridden patient, but then again,
I am sure I will still attempt limb salvage in some patients who are
nonambulatory or bedridden.
Why was endovascular so much better in the octogenarians? I
think it is related to the huge selection bias. We were choosing
bypass for only those who really could not otherwise have any other
option and we were pushing it, as we were pushing endovascular
for the limb salvage for those in whom it was feasible and reason-
able. We may have been a bit too aggressive in very risky patients.
And the limb salvage, therefore, was a result of that selection, and
being aggressive.
Dr Marat Goldenberg (Reading, Pa). I just have one ques-
tion. If you were to stratify the patients and compare the above-
knee procedures with open or endovascular to each other vs below
knee, being that those patients have much worse vascular disease,
do you think your results would not be so different? And with
patients who have severe vascular disease, infrapopliteal vascular
disease, the endovascular results perhaps would not be as good as
above knee.
DrDosluoglu. The infrapopliteal intervention independently
predicted limb loss, but it was really not because of the treatment
modality being bypass or endovascular. The results were not so
different.
As a matter of fact, I have to mention that a good number of
these patients who had absolutely no veins available were
treated with synthetic grafts to the infrapopliteal vessels. So this
is a disadvantaged group of patients. Endovascular is not such a
poor alternative to a synthetic graft distal bypass. Since these
were a consecutive patient series, I am not going to be able to
answer that very easily, because the alternatives are not always
endovascular vs a vein graft to a nondiseased infrapopliteal
vessel.
Dr R. Patterson (Providence, RI). Did you have any patients
who crossed over, who you attempted an endovascular approach
on and were either unsuccessful or their outcome was not what you
wanted and then you subsequently operated on them? And if so,
were their outcomes worse than people who would have had
primary surgery? In other words, did that make those patients
sicker or less satisfactory in their outcome?
Dr Dosluoglu. Especially in the octogenarians, there were no
crossovers in this study group. However, I just had one this week
that I first did an endovascular revascularization and then I per-
formed a bypass. It is not a very common occurrence. When you
have a crossing recanalization failure, then you can do the bypass
but bypass following successful endovascular revascularization is
not a frequent occurrence.
We recently presented a paper in Society for Clinical Vascular
Surgery (SCVS) suggesting that most of the limb losses in the endo-
vascular era actually occur in patientswith patent endovascular-treated
segments. I think this reflects the aggressiveness. Very few of those
actually are attempted to be salvaged by bypass because most of the
time there is actually no target for a bypass procedure. And I do not
think you lose much by doing endovascular at all.Dr Mark G. Davies (Houston, Tex). Were you able to
establish inline flow with each of your endovascular interventions?
This is the current premise of bypass surgery.
Dr Dosluoglu. I actually had that slide, but did not show it
for time constraints. I do not know the exact number, but in-line
flow to the foot was established in over 90% of these patients.
There was no difference in limb loss between those groups. And
the ones that did not have in-line flow established mostly were
those with rest pain.
Dr Davies. I suggest that one way to further stratify your data
might be to use the complexity grading system reported by Faries
et al in a previous paper on superficial femoral artery (SFA) inter-
ventions based on the number of levels intervened on. In that
report the number of levels intervened on was a poor prognostic
factor for outcomes.
Dr Dosluoglu. Just for clarification when I say infrapopliteal,
I meant themost distal was the infrapopliteal. So as a matter of fact,
a significant number of those had multilevel interventions, the
most distal of which was infrapopliteal.
Dr Krish Soundararajan (Philadelphia, Pa). Congratulations
on a very high volume as a single surgeon. I had one quick question
for you.
Intuitively I would have thought that the octogenarians would
have been the group to have aggressive limb salvage with atherec-
tomy as they may not be good surgical candidates. However, I see
that you have used the atherectomy device more often in younger
patients. Is this because of technical reasons or because octogenar-
ians do not have favorable outcome with atherectomy? Could you
share your insights in this regard? Thank you.
Dr Dosluoglu. It is interesting that you picked up on the
atherectomy because that is not a modality that I use a lot. And
apparently, there was a time that I used it and that reflects that time. I
really do not even remember that time, to be honest with you, at this
point, and I cannot really say anything. I do not use it right now.
Dr Robert Y. Rhee (Pittsburgh, Pa). Very interesting results.
I was wondering. What is your surveillance program for patients
who undergo these endovascular interventions? Is it similar to that
of your surgical bypass patients?
Dr Dosluoglu. Actually, we are very aggressive. We bring
them in postoperatively and then at 3 months, 6 months, and every
6 months thereafter. We duplex them and then we do ankle-
brachial indices (ABIs) and assess them clinically.
Of course, I have to admit it is not always easy to image the
infrapopliteal vessels by duplex. So when the technicians are not
sure, we have a low threshold for angiograms for infrapopliteal
interventions especially when there is a clinical suspicion of stag-
nation of ulcer healing or something like that.
Dr Rhee. Do you use a specific criteria?
Dr Dosluoglu. You mean for duplex criteria?
Dr Rhee. Yes.
Dr Dosluoglu. The velocity criteria we would go with three
times the normal velocity increase over the stented segment.
DrRhee.Would you intervene on asymptomatic patients who
develop abnormalities by duplex scanning?
Dr Dosluoglu. If it is a severe disease, if it is more than 70%,
yes. We start watching them closer when they are 50% or above,
and then we would intervene even if it is asymptomatic over 70% to
80%, yes. But it is very rare. Intervention in patients with asymp-
tomatic restenoses is a very rare event.
